Clorox expects fiscal 2027 adjusted EPS near low end of guidance as costs rise

• Clorox expects fiscal 2027 adjusted EPS near the low end of its unchanged $5.70-$6.00 range amid higher costs.
• Input cost headwinds are now estimated at approximately $240 million, driven primarily by higher commodity and transportation costs.
• Net sales growth guidance remains 13%-14%, including about 9.5 percentage points from the GOJO acquisition.
• Organic sales growth remains projected at 3.5%-4.5%, including more than 3.5 percentage points from lapping ERP-related inventory drawdowns.
• Gross margin is now forecast at about 41.5%; selling and administrative expenses are expected at about 15.5% of net sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Clorox Company published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.